glp-1 compounding crackdown news october 2025 The drug shortage is over. What's next for the compounders? - Pharma Technology Focus | Issue 154 Beyond the Headlines: FDA Warning

While not as potent as GLP-1 or dual agonist therapies, Contrave remains a valuable option for select patients who need help managing behavioral and emotional components of eating

Magnesium Malate Great for energy and muscle recovery, tends to work over a few days

Wang W., Pang J., Ha E

Mansur SA, Mieczkowska A, Flatt PR, Bouvard B, Chappard D, Irwin N, Mabilleau G

Insulin-resistant models require co-administration of insulin sensitizers to restore downstream PI3K/Akt signaling even when IGF-1 receptor binding occurs

[1] [2] Treatment intensification should follow a stepwise approach , typically starting with metformin and adding further agents based on individual patient factors such as HbA1c levels, cardiovascular risk, renal function, and patient preference